Comparative in vitro activity of piperacillin-tazobactam and temocillin against third-generation cephalosporin-resistant, carbapenem-susceptible Escherichia coli and Klebsiella pneumoniae

2021/12/21 by Michael Kresken, Kresken, Michael, Yvonne Pfeifer +3
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Antibiotic Resistance in Bacteria #Antibiotic Use and Resistance #Antibiotics Pharmacokinetics and Efficacy #CTX-M #ESBL #Enterobacteriaceae #Germany #Medicine and health

paper · doi:10.3205/id000077

openalex publication_date 2021/12/21 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/19

Abstract

from bloodstream and urinary tract infection samples, with susceptibility rates exceeding those of piperacillin-tazobactam.

Citations

• AmpC β-Lactamases

Related

• Piperacillin/tazobactam versus carbapenems for 30-day mortality in patients with ESBL-producing Enterobacterales bloodstream infections: a retrospective, multicenter, non-inferiority, cohort study
• Establishing piperacillin–tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurements vs. broth microdilution
• Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms
• Revitalizing cephalosporins: The promise of β-lactamase inhibitor combinations
• In vitro susceptibility of cefepime-enmetazobactam, cefepime-taniborbactam and cefepime-zidebactam towards carbapenemase-producing Enterobacterales